Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus

Zsolt Fejes, Szilárd Póliska, Zsolt Czimmerer, Miklós Káplár, András Penyige, Gabriella Gál Szabó, Ildikó Beke Debreceni, Satya P. Kunapuli, J. Kappelmayer, B. Nagy

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Megakaryocyte (MK)-derived miRNAs have been detected in platelets. Here, we analysed the expression of platelet and circulating miR-223, miR-26b, miR-126 and miR-140 that might be altered with their target mRNAs in type 2 diabetes mellitus (DM2). MiRNAs were isolated from leukocyte-depleted platelets and plasma samples obtained from 28 obese DM2, 19 non-DM obese and 23 healthy individuals. The effect of hyperglycaemia on miRNAs was also evaluated in MKs using MEG-01 and K562 cells under hyperglycaemic conditions after 8 hours up to four weeks. Quantitation of mature miRNA, pre-miRNAs and target mRNA levels (P2RY12 and SELP) were measured by RT-qPCR. To prove the association of miR-26b and miR-140 with SELP (P-selectin) mRNA level, overexpression or inhibition of these miRNAs in MEG-01 MKs was performed using mimics or anti-miRNAs, respectively. The contribution of calpain substrate Dicer to modulation of miRNAs was studied by calpain inhibition. Platelet activation was evaluated via surface P-selectin by flow cytometry. Mature and pre-forms of investigated miRNAs were significantly reduced in DM2, and platelet P2RY12 and SELP mRNA levels were elevated by two-fold at increased platelet activation compared to controls. Significantly blunted miRNA expressions were observed by hyperglycaemia in MEG-01 and K562-MK cells versus baseline values, while the manipulation of miR-26b and miR-140 expression affected SELP mRNA level. Calpeptin pretreatment restored miRNA levels in hyperglycaemic MKs. Overall, miR-223, miR-26b, miR-126 and miR-140 are expressed at a lower level in platelets and MKs in DM2 causing upregulation of P2RY12 and SELP mRNAs that may contribute to adverse platelet function.

Original languageEnglish
Pages (from-to)529-542
Number of pages14
JournalThrombosis and Haemostasis
Volume117
Issue number3
DOIs
Publication statusPublished - 2017

Fingerprint

MicroRNAs
Hyperglycemia
Type 2 Diabetes Mellitus
Blood Platelets
Messenger RNA
P-Selectin
Calpain
Megakaryocytes
K562 Cells
Platelet Activation
Flow Cytometry
Leukocytes
Up-Regulation

Keywords

  • Diabetes mellitus
  • Hyperglycaemia
  • Megakaryocyte
  • MicroRNA
  • Platelet activation

ASJC Scopus subject areas

  • Hematology

Cite this

Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. / Fejes, Zsolt; Póliska, Szilárd; Czimmerer, Zsolt; Káplár, Miklós; Penyige, András; Gál Szabó, Gabriella; Beke Debreceni, Ildikó; Kunapuli, Satya P.; Kappelmayer, J.; Nagy, B.

In: Thrombosis and Haemostasis, Vol. 117, No. 3, 2017, p. 529-542.

Research output: Contribution to journalArticle

Fejes, Z, Póliska, S, Czimmerer, Z, Káplár, M, Penyige, A, Gál Szabó, G, Beke Debreceni, I, Kunapuli, SP, Kappelmayer, J & Nagy, B 2017, 'Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus', Thrombosis and Haemostasis, vol. 117, no. 3, pp. 529-542. https://doi.org/10.1160/TH16-04-0322
Fejes, Zsolt ; Póliska, Szilárd ; Czimmerer, Zsolt ; Káplár, Miklós ; Penyige, András ; Gál Szabó, Gabriella ; Beke Debreceni, Ildikó ; Kunapuli, Satya P. ; Kappelmayer, J. ; Nagy, B. / Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. In: Thrombosis and Haemostasis. 2017 ; Vol. 117, No. 3. pp. 529-542.
@article{9b72123aaefe4cb6aa360d5313ce3411,
title = "Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus",
abstract = "Megakaryocyte (MK)-derived miRNAs have been detected in platelets. Here, we analysed the expression of platelet and circulating miR-223, miR-26b, miR-126 and miR-140 that might be altered with their target mRNAs in type 2 diabetes mellitus (DM2). MiRNAs were isolated from leukocyte-depleted platelets and plasma samples obtained from 28 obese DM2, 19 non-DM obese and 23 healthy individuals. The effect of hyperglycaemia on miRNAs was also evaluated in MKs using MEG-01 and K562 cells under hyperglycaemic conditions after 8 hours up to four weeks. Quantitation of mature miRNA, pre-miRNAs and target mRNA levels (P2RY12 and SELP) were measured by RT-qPCR. To prove the association of miR-26b and miR-140 with SELP (P-selectin) mRNA level, overexpression or inhibition of these miRNAs in MEG-01 MKs was performed using mimics or anti-miRNAs, respectively. The contribution of calpain substrate Dicer to modulation of miRNAs was studied by calpain inhibition. Platelet activation was evaluated via surface P-selectin by flow cytometry. Mature and pre-forms of investigated miRNAs were significantly reduced in DM2, and platelet P2RY12 and SELP mRNA levels were elevated by two-fold at increased platelet activation compared to controls. Significantly blunted miRNA expressions were observed by hyperglycaemia in MEG-01 and K562-MK cells versus baseline values, while the manipulation of miR-26b and miR-140 expression affected SELP mRNA level. Calpeptin pretreatment restored miRNA levels in hyperglycaemic MKs. Overall, miR-223, miR-26b, miR-126 and miR-140 are expressed at a lower level in platelets and MKs in DM2 causing upregulation of P2RY12 and SELP mRNAs that may contribute to adverse platelet function.",
keywords = "Diabetes mellitus, Hyperglycaemia, Megakaryocyte, MicroRNA, Platelet activation",
author = "Zsolt Fejes and Szil{\'a}rd P{\'o}liska and Zsolt Czimmerer and Mikl{\'o}s K{\'a}pl{\'a}r and Andr{\'a}s Penyige and {G{\'a}l Szab{\'o}}, Gabriella and {Beke Debreceni}, Ildik{\'o} and Kunapuli, {Satya P.} and J. Kappelmayer and B. Nagy",
year = "2017",
doi = "10.1160/TH16-04-0322",
language = "English",
volume = "117",
pages = "529--542",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - Hyperglycaemia suppresses microrna expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus

AU - Fejes, Zsolt

AU - Póliska, Szilárd

AU - Czimmerer, Zsolt

AU - Káplár, Miklós

AU - Penyige, András

AU - Gál Szabó, Gabriella

AU - Beke Debreceni, Ildikó

AU - Kunapuli, Satya P.

AU - Kappelmayer, J.

AU - Nagy, B.

PY - 2017

Y1 - 2017

N2 - Megakaryocyte (MK)-derived miRNAs have been detected in platelets. Here, we analysed the expression of platelet and circulating miR-223, miR-26b, miR-126 and miR-140 that might be altered with their target mRNAs in type 2 diabetes mellitus (DM2). MiRNAs were isolated from leukocyte-depleted platelets and plasma samples obtained from 28 obese DM2, 19 non-DM obese and 23 healthy individuals. The effect of hyperglycaemia on miRNAs was also evaluated in MKs using MEG-01 and K562 cells under hyperglycaemic conditions after 8 hours up to four weeks. Quantitation of mature miRNA, pre-miRNAs and target mRNA levels (P2RY12 and SELP) were measured by RT-qPCR. To prove the association of miR-26b and miR-140 with SELP (P-selectin) mRNA level, overexpression or inhibition of these miRNAs in MEG-01 MKs was performed using mimics or anti-miRNAs, respectively. The contribution of calpain substrate Dicer to modulation of miRNAs was studied by calpain inhibition. Platelet activation was evaluated via surface P-selectin by flow cytometry. Mature and pre-forms of investigated miRNAs were significantly reduced in DM2, and platelet P2RY12 and SELP mRNA levels were elevated by two-fold at increased platelet activation compared to controls. Significantly blunted miRNA expressions were observed by hyperglycaemia in MEG-01 and K562-MK cells versus baseline values, while the manipulation of miR-26b and miR-140 expression affected SELP mRNA level. Calpeptin pretreatment restored miRNA levels in hyperglycaemic MKs. Overall, miR-223, miR-26b, miR-126 and miR-140 are expressed at a lower level in platelets and MKs in DM2 causing upregulation of P2RY12 and SELP mRNAs that may contribute to adverse platelet function.

AB - Megakaryocyte (MK)-derived miRNAs have been detected in platelets. Here, we analysed the expression of platelet and circulating miR-223, miR-26b, miR-126 and miR-140 that might be altered with their target mRNAs in type 2 diabetes mellitus (DM2). MiRNAs were isolated from leukocyte-depleted platelets and plasma samples obtained from 28 obese DM2, 19 non-DM obese and 23 healthy individuals. The effect of hyperglycaemia on miRNAs was also evaluated in MKs using MEG-01 and K562 cells under hyperglycaemic conditions after 8 hours up to four weeks. Quantitation of mature miRNA, pre-miRNAs and target mRNA levels (P2RY12 and SELP) were measured by RT-qPCR. To prove the association of miR-26b and miR-140 with SELP (P-selectin) mRNA level, overexpression or inhibition of these miRNAs in MEG-01 MKs was performed using mimics or anti-miRNAs, respectively. The contribution of calpain substrate Dicer to modulation of miRNAs was studied by calpain inhibition. Platelet activation was evaluated via surface P-selectin by flow cytometry. Mature and pre-forms of investigated miRNAs were significantly reduced in DM2, and platelet P2RY12 and SELP mRNA levels were elevated by two-fold at increased platelet activation compared to controls. Significantly blunted miRNA expressions were observed by hyperglycaemia in MEG-01 and K562-MK cells versus baseline values, while the manipulation of miR-26b and miR-140 expression affected SELP mRNA level. Calpeptin pretreatment restored miRNA levels in hyperglycaemic MKs. Overall, miR-223, miR-26b, miR-126 and miR-140 are expressed at a lower level in platelets and MKs in DM2 causing upregulation of P2RY12 and SELP mRNAs that may contribute to adverse platelet function.

KW - Diabetes mellitus

KW - Hyperglycaemia

KW - Megakaryocyte

KW - MicroRNA

KW - Platelet activation

UR - http://www.scopus.com/inward/record.url?scp=85014244193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014244193&partnerID=8YFLogxK

U2 - 10.1160/TH16-04-0322

DO - 10.1160/TH16-04-0322

M3 - Article

C2 - 27975100

AN - SCOPUS:85014244193

VL - 117

SP - 529

EP - 542

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -